SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
qiaoxixi
Lv6
3150 积分
2021-06-03 加入
最近求助
最近应助
互助留言
Second Primary Malignancies After Commercial CAR T Cell Therapy: Analysis of FDA Adverse Events Reporting System (FAERS)
1天前
待确认
Therapeutic intersections: Expanding benefits of CD19 CAR T cells from cancer to autoimmunity
1天前
待确认
CAR T‐cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real‐life results of the LOC network
4天前
已完结
CAR-T therapy and targeted treatments: Emerging combination strategies in solid tumors
7天前
已完结
Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30+ lymphoma: a phase 1 study
7天前
已完结
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study
7天前
已完结
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy
7天前
已完结
Understanding Mechanisms of Response to CAR T-cell Therapy through Single-Cell Sequencing: Insights and Challenges
16天前
已完结
Health-related quality of life in patients with triple-class exposed relapsed and refractory multiple myeloma treated with idecabtagene vicleucel or standard regimens: patient-reported outcomes from the phase 3, randomised, open-label KarMMa-3 clinical trial
1个月前
已关闭
Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma
1个月前
已完结
没有进行任何应助
非原文全文
1个月前
感谢
1年前
感谢
1年前
感谢
1年前
内容不对,和标题不符
1年前
感谢
1年前
已找到【积分已退回】
1年前
疑难文献【积分已退回】
1年前
感谢
1年前
考虑采纳
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论